Financials
- Market Capitalization 38.54 M
- Employee 36
- Founded 1997
- CEO N/A
- Website www.nephros.com
- Headquarter Delaware, United States
- FIGI BBG000NXRTF2
- Industry Medical Instruments & Supplies
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4313 | ZTEK Zentek Ltd. - common stock | 0.46 USD | -4.17% | -9.80% | +4.55% | -47.73% | 48.02 M USD | ||
| 4344 | DXR Daxor Corporation - Closed End Fund | 10.65 USD | +5.34% | +4.41% | +5.76% | -22.49% | 44.69 M USD | ||
| 4427 | MLSS Milestone Scientific, Inc. Common Stock | 0.40 USD | 0.00% | +17.65% | +17.65% | -37.50% | 35.23 M USD | ||
| 4520 | HBIO Harvard Bioscience, Inc. - Common Stock | 5.93 USD | -3.10% | -8.63% | -0.34% | +1420.51% | 26.75 M USD |
Frequently asked questions about Nephros, Inc. - Common Stock
What is the Nephros, Inc. - Common Stock stock price today?
The current price of Nephros, Inc. - Common Stock (NEPH) is 3.55. Over the past 24 hours, the stock has changed by -1.11%. Follow the NEPH chart for real-time price dynamics.
What is the stock ticker of Nephros, Inc. - Common Stock?
Nephros, Inc. - Common Stock trades under the ticker NEPH. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Nephros, Inc. - Common Stock stock going up?
NEPH has changed by 0.00% over the last week, +13.78% over the last month, and +1.72% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Nephros, Inc. - Common Stock net income for the last quarter?
Nephros, Inc. - Common Stock reported net income of 140 K for the last quarter. The previous quarter showed 62 K, which means net income changed by +125.81%.
How many employees does Nephros, Inc. - Common Stock have?
As of the latest available data, Nephros, Inc. - Common Stock has 36 employees. Workforce size can provide additional context about the company's scale and operations.
What is Nephros, Inc. - Common Stock EBITDA?
Nephros, Inc. - Common Stock EBITDA is 8.11 M, and its EBITDA margin is 155.58%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Nephros, Inc. - Common Stock stock?
You can buy Nephros, Inc. - Common Stock (NEPH) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Nephros, Inc. - Common Stock stock?
Investing in Nephros, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NEPH chart and related analysis on metatrader.com as part of your research.